An Unbiased Molecular Characterization of Peripartum Cardiomyopathy Hearts Identifies Mast Cell Chymase as a New Diagnostic Candidate
Molecular & Cellular Proteomics · 2026
DOI: 10.1016/j.mcpro.2026.101510 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular & Cellular Proteomics, 2026. Verfasst von J F Mulvey und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. Hauptthemen laut MEDLINE: Peripartum Cardiomyopathy, Chymases, Mast Cells, Myocardium. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, Novo Nordisk Foundation, University of Kentucky.
Abstract (Originalsprache)
Peripartum cardiomyopathy (PPCM) is a rare form of acute heart failure that develops in women toward the end of pregnancy or early postpartum. No effective, specific treatment for PPCM is available and heart transplantation or mechanical circulatory support may be required in severe cases where drug treatment for heart failure is insufficient. The mechanisms through which the disease progresses are not well understood, and despite similar clinical characteristics to dilated cardiomyopathy of other etiologies (nonperipartum cardiomyopathy; NPCM) it is not known how the molecular remodeling differs between these groups. We aimed to provide insight into the human PPCM heart using unbiased methodologies, and to use changes occurring within the heart tissue to facilitate biomarker discovery. We obtained heart tissue from female patients with end-stage disease receiving either heart transplantation or left ventricular assist device implantation, or from organ donors without heart disease as a control group. We performed deep proteomics, single nucleus transcriptomics and spatial transcriptomics, providing a comprehensive map of the molecular phenotype in advanced PPCM compared to both control and NPCM hearts. Consistent with similarities in the clinical phenotypes of PPCM and NPCM, we observed regulation of canonical markers of end-stage heart failure in both PPCM and NPCM hearts in comparison to controls. Among the changes specific to PPCM and that were consistently observed across multiple data types and cohorts was an upregulation of chymase and carboxypeptidase A3, consistent with mast cell proliferation/activation. Analysis of the proteome of peripheral blood serum from a larger cohort of patients with PPCM and controls showed that chymase was strongly predictive of cardiomyopathy in peripartum women. PPCM heart tissue is characterized by increased mast cell proteins chymase and carboxypeptidase A3. Chymase may have clinical utility as a biomarker for the diagnosis of cardiomyopathy in peripartum women.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
- Division of Cardiovascular Biomedicine, University of Kentucky, Lexington, Kentucky, USA.
- Research and Early Development, Novo Nordisk A/S, Måløv, Denmark.
- Department of Cardiology, Rigshospitalet, Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.
- Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. Electronic address: alicia.lundby@sund.ku.dk.
Förderung
- NHLBI NIH HHS
- Novo Nordisk Foundation
- University of Kentucky
- Novo Nordisk A/S
Zitieren
APA
Mulvey, J. F., Sailer, C., Achter, J. S., Milburn, G. N., Bretherton, R. C., Kahnert, K., Erbil Bilir, S., Hvid, H., Pyke, C., Gustafsson, F., Adamo, L., Campbell, K. S., Herum, K. M., & Lundby, A. (2026). An Unbiased Molecular Characterization of Peripartum Cardiomyopathy Hearts Identifies Mast Cell Chymase as a New Diagnostic Candidate. Molecular & Cellular Proteomics. https://doi.org/10.1016/j.mcpro.2026.101510
Vancouver
Mulvey JF, Sailer C, Achter JS, Milburn GN, Bretherton RC, Kahnert K, et al. An Unbiased Molecular Characterization of Peripartum Cardiomyopathy Hearts Identifies Mast Cell Chymase as a New Diagnostic Candidate. Molecular & Cellular Proteomics. 2026. doi:10.1016/j.mcpro.2026.101510
BibTeX
@article{Mulvey2026,
author = {Mulvey, J F and Sailer, C and Achter, J S and Milburn, G N and Bretherton, R C and Kahnert, K and Erbil Bilir, S and Hvid, H and Pyke, C and Gustafsson, F and Adamo, L and Campbell, K S and Herum, K M and Lundby, A},
title = {An Unbiased Molecular Characterization of Peripartum Cardiomyopathy Hearts Identifies Mast Cell Chymase as a New Diagnostic Candidate},
journal = {Molecular & Cellular Proteomics},
year = {2026},
doi = {10.1016/j.mcpro.2026.101510}
}
EUVIMED